BetterLife Obtains Positive TD-0148A Data in Preclinical Models of Depression
Female mice demonstrated clear signs of depression following CVS as indicated by significant reduction in exploratory and grooming behaviors in open-field and splash tests, respectively.
- Female mice demonstrated clear signs of depression following CVS as indicated by significant reduction in exploratory and grooming behaviors in open-field and splash tests, respectively.
- "We are very excited to confirm the projected anti-depressant properties of TD-0148A in rodent depression models conducted by Dr. Aguilar-Valles and his team.
- Dr. Argel Aguilar-Valles commented: We are pleased to collaborate with the BetterLife team in demonstrating the anti-depressant properties of TD-0148A in our models.
- The global depression drugs market reached US$12.41 billion in 2019 and projected to reach near US$25 billion by 2030.